Elsevier

Brain Research

Volume 209, Issue 1, 23 March 1981, Pages 177-188
Brain Research

Barbiturate enhancement of GABA-mediated inhibition and activation of chloride ion conductance: correlation with anticonvulsant and anesthetic actions

https://doi.org/10.1016/0006-8993(81)91179-3Get rights and content

Summary

The anesthetic-sedative barbiturate pentobarbital (PB) and the anticonvulsant barbiturate phenobarbital (PhB) were applied to mammalian spinal cord neurons in primary dissociated cell culture to assess their effects on: (1) postsynaptic GABA-responses; (2) paroxysmal activity produced by the convulsant bicuculline; (3) resting membrane properties; and (4) spontaneous neuronal activity. The results demonstrated that: (1) anticonvulsant actions occured at barbiturate concentrations which augmented GABA-responses; (2) anesthetic actions occurred at barbiturate concentrations which produced direct increases in chloride conductance; (3) both anticonvulsant and anesthetic actions occurred at clinically relevant concentrations; and (4) concentrations of PhB, but not PB, which produced GABA-augmentation and direct conductance changes were widely separated. These findings support the hypotheses that augmentation of GABA-mediated inhibition and possibly reduction of glutamate (GLU)-mediated excitation form the basis at least in part for barbiturate anticonvulsant action and that addition of direct increases in chloride conductance to augmentation of GABA-mediated inhibition and reduction of GLU-mediated excitation may partially underlie anesthetic-sedative barbiturate action.

References (31)

  • BlausteinM.P. et al.

    Barbiturate inhibition of calcium uptake by depolarized nerve terminals in vitro

    Molec. Pharmacol.

    (1975)
  • CohenP.J. et al.

    Signs and stages of anesthesia

  • CutlerR.W.P. et al.

    Effect of barbiturates on release of endogenous amino acids from rat cortex slices

    Neurochem. Res.

    (1979)
  • KalantH. et al.

    Effects of ethanol and pentobarbital on release of acetylcholine from cerebral cortex slices

    J. Pharmacol. exp. Ther.

    (1967)
  • LeppikI.E. et al.

    Intravenous phenytoin and phenobarbital; anticonvulsant action, brain content, and plasma binding in rat

    Epilepsia (Amst.)

    (1979)
  • Cited by (170)

    • Neonatal Abstinence Syndrome: Pharmacological Aspects

      2016, Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions
    • Barbiturates require the N terminus and first transmembrane domain of the δ subunit for enhancement of α1β3δGABA<inf>a</inf> receptor currents

      2010, Journal of Biological Chemistry
      Citation Excerpt :

      At lower concentrations, these compounds allosterically modulate GABAA receptors to potentiate GABAergic currents. At higher concentrations, they can directly activate GABAA receptors in the absence of GABA (2, 7, 8). It has been reported that the barbiturate pentobarbital substantially potentiated peak currents and increased desensitization of α1β3δ receptor currents evoked by saturating concentrations of GABA, but that these effects of pentobarbital were not observed with α1β3γ2L receptor currents at saturating GABA concentrations, although pentobarbital enhanced α1β3γ2L currents at subsaturating GABA concentrations (8), suggesting that the δ subunit rather than the γ2L subunit confers unique “modulatory potential” for this modulator at saturating GABA concentrations.

    • Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy

      2009, Neurobiology of Disease
      Citation Excerpt :

      Our study also provides evidence that the presynaptic effects of PB are distinct from that of the anesthetic barbiturates. The decrease in sIPSC frequency by PB may be related to increase in firing thresholds of presynaptic fibers (Schulz and Macdonald, 1981; Ffrench-Mullen et al., 1993), or due to a decrease in the release probability as a consequence of a direct action by reducing calcium entry to the synaptic terminal (Ondrusek et al., 1979). The data from this study together with results of other studies suggest clear alterations in GABA physiology and pharmacology in limbic epilepsy.

    View all citing articles on Scopus
    View full text